| Value | ₹0.02 Cr |
|---|
NSE filing, NSE: MONOPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Mono Pharmacare Ltd: key numbers
- Share price
- ₹9.30
- Market cap
- ₹16.43 Cr
- Revenue (annual)
- ₹165.7 Cr
- Net profit (annual)
- ₹0.73 Cr
- P/E (TTM)
- 22.4×Sector 46.1×
- Promoter holding
- 56.72%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mono Pharmacare Ltd
All →Mono Pharmacare Other Announcement
Mono Pharmacare declares non-applicability of the Regulation 27(2) corporate governance report for Q2 FY2026-27, as its shares are SME-listed. The filing is a routine compliance exemption notice with no business event.
Mono Pharmacare Other Announcement
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Mono Pharmacare Board Meeting Outcome
Mono Pharmacare Limited's board meeting approved the re-appointment of a director, the appointment of new statutory auditors, and the scheduling of the company's 4th AGM.
Other legal & regulatory announcements
All →Coromandel International Legal & Regulatory
Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.
- Value
- ₹0.18 Cr
Taurian Mps Legal & Regulatory
Taurian MPS received a SEBI adjudication order imposing penalties of Rs.5 lakh on the company, Rs.5 lakh on promoters jointly, and Rs.8 lakh on the merchant banker. The penalties relate to IPO offer document disclosure deficiencies.
- Value
- ₹0.05 Cr
Coromandel International Legal & Regulatory
Coromandel International received a GST Order-in-Appeal confirming a ₹1.79 Crore tax demand. Including interest and penalty, the total is ₹4.05 Crore; the company will appeal.
- Value
- ₹4.05 Cr
Shreeji Global FMCG Legal & Regulatory
Shreeji Global FMCG received a customs Order-in-Original demanding about ₹42.47 Crore in duty, penalties and redemption fines. The company plans to appeal before CESTAT.
- Value
- ₹42.47 Cr
HD Fire Protect Legal & Regulatory
HD Fire Protect received an MPCB refusal of Consent to Operate for its Jalgaon expansion sheds. Existing manufacturing operations continue, with no material impact anticipated.
Krishna Institute of Medical Sciences Legal & Regulatory
KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.